Quest Diagnostics (DGX) PT Raised to $115 at UBS; 'Improved Growth Profile Continues to Build Confidence'
Tweet Send to a Friend
UBS raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
